A Comparative Clinical Study To Evaluate The Efficacy Of Shatpushpa Taila Nasya And Shatpushpa Taila Nasya Along With Shatpushpa Churna Orally In Artavkshaya W.S.R To Oligomenorrhea And Hypomenorrhea

Aim : To evaluate the efficacy of shatpushpa taila nasya along with Shatpushpa churna orally in Artavkshaya Objectives:   To study artavakshaya in detail along with its possible modern correlations    To establish an ayurvedic medication as a remedy for artavakshaya.   To compare the efficacy of shatpushpa taila nasya and shatpushpataila nasya along with shatpushpa choorna in Artavkshay

Hypothesis :

Null hypothesis (H0) :      Shatpushpa taila Nasya along with shatpushpa choorna is not  as effective as  shatpushpa taila nasya  in the management of artakshaya .

Alternative Hypothesis- (H1)  Shatpushpa taila Nasya along with shatpushpa  choorna is as effective as Shatpushpa taila nasya in Artavkshaya .

Assesment criteria

subjective criteria .

a) Duration of Menstrual bleeding**:**3-5 DAYS (normal duration)-0 ,2 DAYS (moderately short duration)-1 ,1 DAYS (short duration)-2, Spotting (very short duration)-3

b) Interval between two menstrual cycle : 24-34 DAYS -score 0, 35-39 DAYS- score 1 ,40-45 DAYS score-2,  ABOVE 45  score- 3

c) Quantity of bleeding or Using number of Pad /Day during Period: >2 Pad/day-0 ,2 Pad/day-1 ,1 Pad/day-2 , Spotting-3

d) Pain during Menstrual bleeding (Pelvic Pain**)**No pain-0,  Mild (Able to do daily activity) -1,Moderate (Daily activities affected, need to take analgesics) -2 ,Severe (Daily activities affected ,pain continuous after taking analgesics) - 3

e) Pattern of Menstrual cycle (Regular/Irregular)Regular cycle-0, Irregular cyclep-1.

f) Bleeding /Spotting between periods : Absent- 0, Present-1

g) Consistency of Menstrual bleeding :Thin-0, Mucoid -1, Mucoid with clots -2 ,Clots -3

h) Color of Bleeding/*Srava :*Shuddha Rakta Srava - 0,  Arun,KrishnaSrava (Vatajadushti) or -Neela,PittaSrava (Pittajadushti) or**Shukla, PchhilaSrava (Kaphajadushti) - 1

i) BackacheNo pain -  0 , Mild (Able to do daily activity) - 1 ,Moderate (Daily activities affected, need to take analgesics) -2, Severe (Daily activities affected,pain continuous after taking analgesics) - 3

Objective parameters  BMI Underweight <18.5 kg/m 2  - 0,   Normal weight 18.5-24.9 kg/m 2 -1, Overweight 25-29.9 kg/m 2 -2, Obese ≥ 30 kg/m 2 - 3

Intervention

Group

Group- A (Control Group of 20 Patients)

Group-B  (Trial Group of 20 Patients)

|Drug

Shatpushpa taila nasya

Shatpushpa taila nasya along with shatpyshpa choorna orally

|Route

Nasal route

Nasal and orally

|Dose

2 drops in each nostril, 7 days before LMP

Nasya :-2 drops in each nostril, 7 days before LMP

Choorna :- 3 gm BD with luke warm water

|Duration

For 2 consecutive cycle

For 2 consecutive cycle

|Follow up

After completion of each menstruation for 2 Consecutive Cycle

After completion of each menstruation for 2 Consecutive Cycle

|Final followup

In 3rd month (without medicine )

In 3rd month (without medicine)

Study durationTotal 3 months (2 months for treatment & after 1 month final follow up)

Follow upFollowup during treatment : Each menstrual  cycle for 2 consecutive cycle Final follow up : on  3rdmenstrual  cycle

Laboratory Investigations 1)CBC 2)U.S.G (PELVIS)